In SSc, circulating monocytes and tissue-resident macrophages, potentially under the influence of type 2 cytokines (IL-4, IL-13), appear to preferentially express CD163 and CD204 and promote fibrogenesis by increasing the production of TGF-β. Here, IL13 is linked to systemic sclerosis.